Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
25 and 50 mg diclofenac K film coated immediate release tablets More
Topical Diclofenac formulations for the treatment of inflammatory and painful conditions More
25mg dosage strenght for the OTC market in film coated tablets More
Adhesive Patch of 90 sq. cm. and containing as active ingredient 100 mg. of ketoprofen for the local treatment of traumatic injuries and extra-articular rheumatism More
Collagen-based biodegradable matrices for localized drug delivery More
Fentanyl patch for the management of severe pain in patients who require continuous opioid analgesia. More
Transdermal pain patch for the treatment of moderate to severe chronic pain. More
The First Line of Therapy in Severe Migraine Attacks More
5 and 10 mg Donepezil are under final development using the proprietary RapidFilm drug delivery Technology securing fast dissolution in the oral cavity without the need of water More
4 and 8 mg Ondansetron ready for submission in EU (exp. Q4/08) using the proprietary RapidFilm drug delivery Technology securing fast dissolution in the oral cavity without the need of water More
Related Reports
Market Research Reports provided by reports.innovaro.com
Jun 2006 - 1068 pages - $2,495
Sep 2011 - 97 pages - $3,500
Apr 2010 - 510 pages - $2,695
Feb 2011 - 209 pages - $3,500
Jun 2010 - 319 pages - $2,695
Oct 2010 - 53 pages - $1,000
Feb 2011 - 75 pages - $1,000
Jun 2010 - 411 pages - $2,695
Jan 2010 - $75
May 2010 - 263 pages - $2,695
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Therapeutic target
- Age-related disorders (other)
- Amyotrophic lateral sclerosis
- CNS (other)
- Neurodegenerative disorders
- Neurological
- Pain
- Psychiatric
- Subarachnoid hemorrhage
- Traumatic brain injury
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us